20,792
Total Claims
$910K
Drug Cost
1,435
Beneficiaries
$634
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-58%
Cost per patient vs peers
$634 vs $1,524 avg
-37%
Brand preference vs peers
8.6% vs 13.7% avg
Brand vs Generic
91% generic
Brand: 1,788 claims · $616K
Generic: 19,004 claims · $294K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 350 | $214K |
| Rivaroxaban | 227 | $139K |
| Ticagrelor | 257 | $127K |
| Dapagliflozin Propanediol | 91 | $55K |
| Candesartan/Hydrochlorothiazid | 339 | $44K |
| Candesartan Cilexetil | 556 | $43K |
| Omega-3 Acid Ethyl Esters | 681 | $34K |
| Metoprolol Succinate | 2,122 | $25K |
| Levothyroxine Sodium | 261 | $15K |
| Sacubitril/Valsartan | 21 | $14K |
| Atorvastatin Calcium | 1,700 | $13K |
| Losartan Potassium | 1,144 | $11K |
| Irbesartan | 630 | $10K |
| Telmisartan/Hydrochlorothiazid | 92 | $8,969 |
| Rosuvastatin Calcium | 976 | $8,414 |
Prescribing Profile
86
Unique Drugs
$423K
Patient Profile
73
Avg Age
58%
Female
2.03
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data